CVS Health Corporation

Hi, good morning, everyone. My name is Erin Wright. I'm the lead healthcare services analyst at Morgan Stanley. Just real quickly, for more important disclosures, please see the Morgan Stanley Research Disclosure website at www.morganstanley.com. If you have any questions, please reach out to your Morgan Stanley sales representative. And with that, we're happy to have CVS Health with us this morning. With them, we have Karen Lynch, President and CEO. Thank you. As well as Sean Gerton, EVP and CFO. And then we have Larry McGrath in the audience as well. So, I will hand it over to Sean for your disclosures.

Great. Thank you. Thank you. Good morning, everyone. I just want to remind everyone today that we will be making forward-looking statements today, and you should consult our SEC filings for a description of the risks inherent in those statements as well as the risks inherent in our business and our most recently filed 10-Q and 10-K and other relevant violence.

Great. Thank you, Sean. We'll definitely get into some of the topical questions on PBMs, utilization, STARS, but I do want to talk a little bit about, Karen, the efforts to strengthen the power of the whole enterprise. With the Signify deal, Oak Street deal, it's been three months since the closure of those deals. How has it progressed relative to your expectations? Where are we at in terms of that integrated approach and your vision there? And can you talk a little bit about what synergies have materialized even thus far?